US Stock MarketDetailed Quotes

TSHA Taysha Gene Therapies

Watchlist
  • 3.2400
  • +0.2400+8.00%
Close Nov 29 13:00 ET
  • 3.2700
  • +0.0300+0.93%
Post 16:44 ET
664.02MMarket Cap5.14P/E (TTM)

Taysha Gene Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-62.33%1.79M
-53.57%1.11M
-27.52%3.41M
517.55%15.45M
44.04%3.6M
4.75M
2.4M
4.71M
2.5M
2.5M
Operating revenue
-62.33%1.79M
-53.57%1.11M
-27.52%3.41M
517.55%15.45M
44.04%3.6M
--4.75M
--2.4M
--4.71M
--2.5M
--2.5M
Cost of revenue
Gross profit
Operating expense
12.11%22.85M
-13.06%22.41M
30.45%27.74M
-32.45%86.83M
-3.23%19.4M
-19.94%20.38M
-22.75%25.78M
-57.17%21.27M
-25.82%128.53M
-59.68%20.05M
Selling and administrative expenses
-8.00%7.9M
22.55%7.34M
-19.05%7.08M
-19.57%30.05M
-8.47%6.72M
-1.08%8.59M
-39.31%5.99M
-23.70%8.75M
-9.59%37.36M
-37.82%7.34M
-General and administrative expense
-8.00%7.9M
22.55%7.34M
-19.05%7.08M
-19.57%30.05M
-8.47%6.72M
-1.08%8.59M
-39.31%5.99M
-23.70%8.75M
-9.59%37.36M
-37.82%7.34M
Research and development costs
26.76%14.95M
-23.84%15.07M
65.07%20.66M
-37.72%56.78M
-0.20%12.68M
-29.71%11.79M
-15.80%19.79M
-67.23%12.51M
-30.90%91.17M
-66.49%12.71M
Operating profit
-34.71%-21.06M
8.92%-21.3M
-46.93%-24.33M
43.37%-71.37M
9.97%-15.8M
38.59%-15.63M
29.93%-23.38M
66.65%-16.56M
27.26%-126.03M
64.71%-17.55M
Net non-operating interest income expense
675.41%2.08M
216.11%1.41M
257.73%1.66M
59.82%-1.43M
209.22%1.21M
66.14%-362K
-69.97%-1.22M
-60.33%-1.06M
-182.56%-3.55M
-67.07%-1.11M
Non-operating interest income
89.99%2.11M
545.74%1.44M
430.72%1.69M
1,334.54%3.57M
865.33%1.92M
12,222.22%1.11M
725.93%223K
2,178.57%319K
44.77%249K
586.21%199K
Non-operating interest expense
-98.37%24K
-98.13%27K
-97.89%29K
31.60%5M
-45.36%713K
36.46%1.47M
93.81%1.44M
104.46%1.37M
165.97%3.8M
88.86%1.31M
Other net income (expense)
93.52%-6.55M
-34,833.33%-1.04M
-17,337.50%-1.4M
-6.39%-38.77M
271.11%62.33M
-10,109,000.00%-101.09M
200.00%3K
0.00%-8K
-36.44M
-36.43M
Gain on sale of security
100.07%75K
--195K
---337K
---34.72M
--65.74M
---100.46M
----
----
----
----
Special income (charges)
-685.39%-4.84M
----
----
93.24%-2.46M
94.93%-1.85M
---616K
----
----
---36.42M
---36.42M
-Less:Impairment of capital assets
685.39%4.84M
----
----
-97.08%1.07M
-98.77%449K
--616K
----
----
--36.42M
--36.42M
-Less:Other special charges
----
----
----
--1.4M
----
----
----
----
----
----
Other non- operating income (expenses)
-9,289.47%-1.78M
-41,333.33%-1.24M
-13,125.00%-1.06M
-8,705.56%-1.59M
-25,916.67%-1.56M
-1,800.00%-19K
200.00%3K
0.00%-8K
---18K
---6K
Income before tax
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
-341.39%-117.09M
27.85%-24.6M
64.98%-17.62M
4.88%-166.01M
-9.31%-55.08M
Income tax
Net income
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
-341.39%-117.09M
27.85%-24.6M
64.98%-17.62M
4.88%-166.01M
-9.31%-55.08M
Net income continuous Operations
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
-341.39%-117.09M
27.85%-24.6M
64.98%-17.62M
4.88%-166.01M
-9.31%-55.08M
Minority interest income
Net income attributable to the parent company
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
-341.39%-117.09M
27.85%-24.6M
64.98%-17.62M
4.88%-166.01M
-9.31%-55.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
-341.39%-117.09M
27.85%-24.6M
64.98%-17.62M
4.88%-166.01M
-9.31%-55.08M
Basic earnings per share
89.25%-0.1
76.32%-0.09
64.29%-0.1
74.60%-0.96
125.79%0.2554
-43.08%-0.93
55.29%-0.38
78.79%-0.28
18.53%-3.78
25.00%-0.99
Diluted earnings per share
89.25%-0.1
76.32%-0.09
64.29%-0.1
74.60%-0.96
125.79%0.2554
-43.08%-0.93
55.29%-0.38
78.79%-0.28
18.53%-3.78
25.00%-0.99
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -62.33%1.79M-53.57%1.11M-27.52%3.41M517.55%15.45M44.04%3.6M4.75M2.4M4.71M2.5M2.5M
Operating revenue -62.33%1.79M-53.57%1.11M-27.52%3.41M517.55%15.45M44.04%3.6M--4.75M--2.4M--4.71M--2.5M--2.5M
Cost of revenue
Gross profit
Operating expense 12.11%22.85M-13.06%22.41M30.45%27.74M-32.45%86.83M-3.23%19.4M-19.94%20.38M-22.75%25.78M-57.17%21.27M-25.82%128.53M-59.68%20.05M
Selling and administrative expenses -8.00%7.9M22.55%7.34M-19.05%7.08M-19.57%30.05M-8.47%6.72M-1.08%8.59M-39.31%5.99M-23.70%8.75M-9.59%37.36M-37.82%7.34M
-General and administrative expense -8.00%7.9M22.55%7.34M-19.05%7.08M-19.57%30.05M-8.47%6.72M-1.08%8.59M-39.31%5.99M-23.70%8.75M-9.59%37.36M-37.82%7.34M
Research and development costs 26.76%14.95M-23.84%15.07M65.07%20.66M-37.72%56.78M-0.20%12.68M-29.71%11.79M-15.80%19.79M-67.23%12.51M-30.90%91.17M-66.49%12.71M
Operating profit -34.71%-21.06M8.92%-21.3M-46.93%-24.33M43.37%-71.37M9.97%-15.8M38.59%-15.63M29.93%-23.38M66.65%-16.56M27.26%-126.03M64.71%-17.55M
Net non-operating interest income expense 675.41%2.08M216.11%1.41M257.73%1.66M59.82%-1.43M209.22%1.21M66.14%-362K-69.97%-1.22M-60.33%-1.06M-182.56%-3.55M-67.07%-1.11M
Non-operating interest income 89.99%2.11M545.74%1.44M430.72%1.69M1,334.54%3.57M865.33%1.92M12,222.22%1.11M725.93%223K2,178.57%319K44.77%249K586.21%199K
Non-operating interest expense -98.37%24K-98.13%27K-97.89%29K31.60%5M-45.36%713K36.46%1.47M93.81%1.44M104.46%1.37M165.97%3.8M88.86%1.31M
Other net income (expense) 93.52%-6.55M-34,833.33%-1.04M-17,337.50%-1.4M-6.39%-38.77M271.11%62.33M-10,109,000.00%-101.09M200.00%3K0.00%-8K-36.44M-36.43M
Gain on sale of security 100.07%75K--195K---337K---34.72M--65.74M---100.46M----------------
Special income (charges) -685.39%-4.84M--------93.24%-2.46M94.93%-1.85M---616K-----------36.42M---36.42M
-Less:Impairment of capital assets 685.39%4.84M---------97.08%1.07M-98.77%449K--616K----------36.42M--36.42M
-Less:Other special charges --------------1.4M------------------------
Other non- operating income (expenses) -9,289.47%-1.78M-41,333.33%-1.24M-13,125.00%-1.06M-8,705.56%-1.59M-25,916.67%-1.56M-1,800.00%-19K200.00%3K0.00%-8K---18K---6K
Income before tax 78.20%-25.52M14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M-341.39%-117.09M27.85%-24.6M64.98%-17.62M4.88%-166.01M-9.31%-55.08M
Income tax
Net income 78.20%-25.52M14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M-341.39%-117.09M27.85%-24.6M64.98%-17.62M4.88%-166.01M-9.31%-55.08M
Net income continuous Operations 78.20%-25.52M14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M-341.39%-117.09M27.85%-24.6M64.98%-17.62M4.88%-166.01M-9.31%-55.08M
Minority interest income
Net income attributable to the parent company 78.20%-25.52M14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M-341.39%-117.09M27.85%-24.6M64.98%-17.62M4.88%-166.01M-9.31%-55.08M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 78.20%-25.52M14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M-341.39%-117.09M27.85%-24.6M64.98%-17.62M4.88%-166.01M-9.31%-55.08M
Basic earnings per share 89.25%-0.176.32%-0.0964.29%-0.174.60%-0.96125.79%0.2554-43.08%-0.9355.29%-0.3878.79%-0.2818.53%-3.7825.00%-0.99
Diluted earnings per share 89.25%-0.176.32%-0.0964.29%-0.174.60%-0.96125.79%0.2554-43.08%-0.9355.29%-0.3878.79%-0.2818.53%-3.7825.00%-0.99
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data